Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

Published:2014-05 Issue:5 Volume:13 Page:461-471
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Michelson David,Snyder Ellen,Paradis Erin,Chengan-Liu Mary,Snavely Duane B,Hutzelmann Jill,Walsh James K,Krystal Andrew D,Benca Ruth M,Cohn Martin,Lines Christopher,Roth Thomas,Herring W Joseph

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference29 articles.

1. Chronic insomnia: clinical and research challenges—an agenda;Riemann;Pharmacopsychiatry,2011

2. Chronic insomnia;Morin;Lancet,2012

3. Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study;Roehrs;J Psychopharmacol,2012

4. Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study;Randall;Sleep,2012

5. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia;Mayer;Sleep,2009

Cited by 341 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement in self-reported, but not actigraphic, sleep measures with suvorexant in people with well-controlled Restless Legs Syndrome and persistent insomnia;Sleep Medicine;2024-12

2. Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review;Translational Psychiatry;2024-09-14

3. Hypocretin receptor antagonists prevent opioid addiction;Nature Mental Health;2024-08-23

4. Exploring triazole-based drugs: Synthesis, application, FDA approvals, and clinical trial updates–A comprehensive review;Tetrahedron;2024-08

5. Association between the use of orexin receptor antagonists and falls or fractures: A meta-analysis;Journal of Psychiatric Research;2024-08